Webinar Series Annex 1 - Application of Disinfectants and their Validation

Thursday, 9 July 2020 14.00 - 15.30 h

Course No. 18068



Dr.  Thomas Meindl

Dr. Thomas Meindl

Labor LS

Important: Deadline is 12 noon on 8 July 2020You will find all webinars of this series in this overview


Annex 1 “Manufacture of sterile medicinal products” of the EU GMP Guide is currently being revised. A first draft of the revised version was published in 2017 and released for public comment, which resulted in thousands of comments. A revised version was published in February 2020 and is open for limited comment by selected stakeholders.

Target Group

This conference is of interest to professionals from pharmaceutical and biopharmaceutical manufacturers, authorities and suppliers with responsibilities in
  • Aseptic Manufacturing, Quality Assurance, Quality Control, Auditing, Inspections
who are involved in
  • Contamination Control, Monitoring, Qualification and Validation, Self Inspection, Quality Affairs, Process Simulation/Media Fill

Technical Requirements

For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings.

At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in.  Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.


This webinar will inform you about the requirements for the use of disinfectants in pharmaceutical production, which are formulated in more detail in the new Annex.

Starting from a qualified cleaning, a disinfection strategy must be developed and validated as part of the Contamination Control Strategy. The validation shows that the methods, processes and materials described lead to the desired result under the individual clean room conditions. An important prerequisite for this is up-to-date data on the respective house germ flora. The selection of disinfectants is based on the results of operational hygiene monitoring as well as on risk-based approaches, which can be used to plan the frequency of use and the selection of disinfectants.
  • Inhouse Isolates as a basis for decision-making for a risk-based approach
  • Suitable disinfectant validation
  • Evaluation of disinfectant studies

ECA-Member*: € 199,-
Non ECA Member*: € 249,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

Further dates on-site
Further dates on-site
Not available
Further dates online
Further dates online
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023


“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024


“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024



“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023